MannKind appointed former Novartis global development head James Shannon to its board. Shannon, who is now president and CEO of Cerimon Pharmaceuticals, left Novartis in 2008. MannKind markets Afrezza for type 1 and type 2 diabetes as well as control of hyperglycemia, and has several products in Phase 1 clinical trials.
Ignite Health named Matt Brown president. Brown was previously COO. He replaces Jackie Herr, who is retiring from the Irvine, CA-based inVentiv Health company at the end of March.